Patient Enrollment For Global Diabetes/CVO Study

This seven-year outcomes study was critical to the success of a compound that is expected to build on the sponsor’s leadership position in diabetes care. Because of the study’s importance, as well as the costs associated with this multiyear program, keeping enrollment and study timelines on track was of paramount importance to the sponsor.

Six months after the study was begun, the CRO was still struggling to initiate sites, and patient enrollment rates were abysmal. See what happened next.